Literature DB >> 10837087

Detection of circulating epithelial cells after surgery for benign breast disease.

D Crisan1, D S Ruark, D A Decker, A M Drevon, R G Dicarlo.   

Abstract

BACKGROUND: Cytokeratins are predominantly expressed in epithelial cells and their malignant counterparts. Ultrasensitive methods for cytokeratin messenger RNAs (mRNAs) can detect rare circulating tumor cells consistent with hematogenous dissemination in epithelial-derived malignancies, including breast carcinomas. Intraoperative tumor-cell shedding may contribute to this process; this hypothesis is based on the assumption that only tumor cells can be mobilized during surgical manipulation. METHODS AND
RESULTS: The present study addresses this issue by using cytokeratin 19 mRNA detection by reverse transcription-polymerase chain reaction (RT-PCR) in preoperative and postoperative blood samples from 54 patients undergoing excisional biopsy for benign breast disease; 22 healthy volunteers represented the control group. No cytokeratin RT-PCR positivity was found in the control or preoperative samples. Cytokeratin RT-PCR positivity was found in 21 postoperative samples (39%).
CONCLUSIONS: This finding shows that benign epithelial cells can be mobilized during breast surgery; this effect of surgical manipulation warrants caution in the interpretation of RT-PCR positivity for cytokeratin mRNA in the peripheral blood of patients undergoing surgery for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837087     DOI: 10.1007/bf03262020

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  27 in total

1.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction.

Authors:  S T Traweek; J Liu; H Battifora
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

2.  Does the timing of breast cancer surgery affect survival?

Authors:  J Randal
Journal:  J Natl Cancer Inst       Date:  1997-04-02       Impact factor: 13.506

3.  Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins.

Authors:  P C Stasiak; P E Purkis; I M Leigh; E B Lane
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

4.  Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogene sequence.

Authors:  E S Savtchenko; T A Schiff; C K Jiang; I M Freedberg; M Blumenberg
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

5.  Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.

Authors:  M Novaes; I Bendit; B Garicochea; A del Giglio
Journal:  Mol Pathol       Date:  1997-08

6.  Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells.

Authors:  M C Eaton; J E Hardingham; D Kotasek; A Dobrovic
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

7.  Keratin 19 expression in the adult and developing human mammary gland.

Authors:  J Bartek; J Bartkova; J Taylor-Papadimitriou
Journal:  Histochem J       Date:  1990-10

8.  Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

Authors:  Y H Datta; P T Adams; W R Drobyski; S P Ethier; V H Terry; M S Roth
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

Review 9.  Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors.

Authors:  T J Pelkey; H F Frierson; D E Bruns
Journal:  Clin Chem       Date:  1996-09       Impact factor: 8.327

10.  Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.

Authors:  S Noguchi; T Aihara; K Motomura; H Inaji; S Imaoka; H Koyama
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more
  8 in total

Review 1.  Circulating tumor cell technologies.

Authors:  Meghaan M Ferreira; Vishnu C Ramani; Stefanie S Jeffrey
Journal:  Mol Oncol       Date:  2016-01-28       Impact factor: 6.603

2.  Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.

Authors:  Tina Fan; Qiang Zhao; John J Chen; Wen-Tien Chen; Michael L Pearl
Journal:  Gynecol Oncol       Date:  2008-10-26       Impact factor: 5.482

Review 3.  Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo.

Authors:  Jin-Woo Kim; Ekaterina I Galanzha; David A Zaharoff; Robert J Griffin; Vladimir P Zharov
Journal:  Mol Pharm       Date:  2013-02-25       Impact factor: 4.939

4.  Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor.

Authors:  André A Adams; Paul I Okagbare; Juan Feng; Matuesz L Hupert; Don Patterson; Jost Göttert; Robin L McCarley; Dimitris Nikitopoulos; Michael C Murphy; Steven A Soper
Journal:  J Am Chem Soc       Date:  2008-06-17       Impact factor: 15.419

5.  DNA methylation as a potential diagnosis indicator for rapid discrimination of rare cancer cells and normal cells.

Authors:  Xingyu Si; Yaoyao Zhao; Chengdui Yang; Sichun Zhang; Xinrong Zhang
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

Review 6.  Technologies for circulating tumor cell separation from whole blood.

Authors:  Petra Bankó; Sun Young Lee; Viola Nagygyörgy; Miklós Zrínyi; Chang Hoon Chae; Dong Hyu Cho; András Telekes
Journal:  J Hematol Oncol       Date:  2019-05-14       Impact factor: 17.388

7.  Cytology and cell-block immunohistochemistry of circulating tumour cells.

Authors:  Frederick George Mayall; Justin Pepperell; Ian Bodger; Daniel Higbee; Lara Stevanato; Arianna Hustler; Kyra Mhairi Mumford
Journal:  Cytopathology       Date:  2019-10-08       Impact factor: 2.073

8.  The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.

Authors:  I Van der Auwera; H J Elst; S J Van Laere; H Maes; P Huget; P van Dam; E A Van Marck; P B Vermeulen; L Y Dirix
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.